Abstract | AIM: METHODS: Human breast cancer cell line MCF-7 and human hepatocellular carcinoma cell line HepG2 were examined. The cell proliferation was assessed using a sulforhodamine B assay. Western blotting and radioactivity assays were used to analyze the phosphorylation of AMPK. The DNA synthesis was analyzed with BrdU incorporation. Nude mice bearing MCF-7 cell xenografts were used to for in vivo study. MTX (50 mg/kg, ip, per week) and AICA riboside (200 mg/kg, ip, every other day) were administered the animals for 2 weeks. The concentrations of AICA riboside and its active metabolite AICA ribotide in the plasma and tumors were measured with HPLC. RESULTS: Synergistic cytotoxicity in vitro was observed with MTX (0.1, 0.5, and 1 μmol/L) combined with AICA riboside (0.25-1 mmol/L) in MCF-7 cells, and with MTX (0.5 and 1 μmol/L) combined with AICA riboside (0.5 and 1 mmol/L) in HepG2 cells. MTX (1 μmol/L) significantly enhanced the AICA riboside-induced AMPK activation and BrdU incorporation in both MCF-7 and HepG2 cells. Co-treatment with MTX and AICA riboside exerted more potent inhibition on the tumor growth in nude mice than either drug alone. After injection of AICA riboside (200 mg/kg, iv) in nude mice bearing MCF-7 xenografts, MTX (50 mg/kg, iv) significantly increased the concentrations of AICA riboside and its active metabolite AICA ribotide in tumors. CONCLUSION: MTX and AICA riboside exert synergistic anticancer action against MCF-7 and HepG2 cells in vitro and in vivo. MTX increases the concentration of AICA riboside and its active metabolite AICA ribotide in tumors in vivo.
|
Authors | Xiao-liang Cheng, Tian-yan Zhou, Bo Li, Meng-yao Li, Liang Li, Zai-quan Li, Wei Lu |
Journal | Acta pharmacologica Sinica
(Acta Pharmacol Sin)
Vol. 34
Issue 7
Pg. 951-9
(Jul 2013)
ISSN: 1745-7254 [Electronic] United States |
PMID | 23603981
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Aminoimidazole Carboxamide
- Methotrexate
|
Topics |
- Aminoimidazole Carboxamide
(administration & dosage)
- Animals
- Apoptosis
(drug effects, physiology)
- Breast Neoplasms
(drug therapy, pathology)
- Carcinoma, Hepatocellular
(drug therapy, pathology)
- Cell Proliferation
(drug effects)
- Drug Synergism
- Female
- Hep G2 Cells
- Humans
- Liver Neoplasms, Experimental
(drug therapy, pathology)
- MCF-7 Cells
- Methotrexate
(administration & dosage)
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Xenograft Model Antitumor Assays
(methods)
|